記述言語：英語   出版者・発行元：Journal of Cardiovascular Electrophysiology  

Background: Patients are prone to bradyarrhythmias after Fontan surgery due to anatomical reasons and the surgery, whereas a transvenous approach to a cardiac chamber is difficult in patients after total cavopulmonary artery connection (TCPC) with an extracardiac conduit. Methods and Results: We report a case of transvenous implantation of an atrial lead into the atrial roof via the pulmonary artery and a successful upgrade to the dual chamber pacing using an existing epicardial ventricular lead. Conclusion: A transvenous approach toward atrial roof via pulmonary artery may be a possible option in patients with TCPC. If successful, high-risk additional surgery can be avoided.

DOI： 10.1111/jce.16626

Web of Science

Scopus

PubMed

記述言語：英語   出版者・発行元：一般社団法人 日本循環器学会  

<p>The 87^thAnnual Meeting of the Japanese Circulation Society (JCS2023) was held in March 2023 in Fukuoka, Japan, marking the first in-person gathering after the COVID-19 pandemic. With the theme of “New Challenge With Next Generation” the conference emphasized the development of future cardiovascular leaders and technologies such as artificial intelligence (AI). Notable sessions included the Mikamo Lecture on heart failure and the Mashimo Lecture on AI in medicine. Various hands-on sessions and participatory events were well received, promoting learning and networking. Post-event surveys showed high satisfaction among participants, with positive feedback on face-to-face interactions and the overall experience. JCS2023, attended by 17,852 participants, concluded successfully, marking a significant milestone in post-pandemic meetings, and advancing cardiovascular medicine.</p>

DOI： 10.1253/circj.cj-24-0127

Web of Science

PubMed

CiNii Research

記述言語：英語  

DOI： 10.1111/pace.14906

Web of Science

PubMed

記述言語：日本語   出版者・発行元：一般社団法人 日本超音波検査学会  

DOI： 10.11272/jssabst.49.0_s143

CiNii Research

記述言語：英語   出版者・発行元：JACC: Clinical Electrophysiology  

Background: Advances in catheter ablation (CA) for atrial fibrillation (AF) have improved the prognosis of patients with heart failure (HF) and AF. However, its optimal timing remains to be fully elucidated. Objectives: The aim of this study was to investigate the prognostic impact of early CA in patients with HF and AF hospitalized for worsening HF. Methods: From JROADHF (Japanese Registry of Acute Decompensated Heart Failure) (n = 13,238), patients with HF and AF who underwent CA within 90 days after admission for HF (early CA; n = 103) and those who did not (control; n = 2,683) were identified. Mortality was compared between these groups in the crude cohort, as well as in the propensity-matched cohort (n = 83 in each group). Results: In the crude cohort, all-cause mortality was significantly lower in the early CA group than in the control group (log-rank P < 0.001; HR: 0.38; 95% CI: 0.24-0.60). In the matched cohort, all-cause mortality was likewise significantly lower in the early CA group (log-rank P = 0.014; HR: 0.47; 95% CI: 0.25-0.88). Cardiovascular death and HF mortality were significantly lower in both cohorts (crude: Gray’ test: P < 0.001 and P = 0.005; subdistribution HR: 0.28 [95% CI: 0.13-0.63] and HR: 0.31 [95% CI: 0.13-0.75]; matched: Gray's test: P = 0.006 and P = 0.017; subdistribution HR: 0.24 [95% CI: 0.08-0.70] and HR: 0.28 [95% CI: 0.09-0.84], respectively). Conclusions: In a nationwide representative real-world cohort, CA for AF within 90 days after admission for HF was associated with improved long-term outcomes, including cardiovascular and HF death in patients with HF and AF.

DOI： 10.1016/j.jacep.2023.05.038

Web of Science

Scopus

PubMed

記述言語：日本語  

記述言語：英語  

記述言語：日本語  

記述言語：英語  

記述言語：日本語